|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 12,102,754: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 12,102,754?
U.S. Patent 12,102,754 (hereafter "the patent") grants exclusive rights over a specific pharmaceutical compound or method related to a therapeutic area. The patent's scope is primarily defined by the claims, which specify the legal boundaries for protection.
The patent focuses on a novel chemical entity or a pharmaceutical composition for treating a particular condition. The claims include:
- A chemical compound with defined structural features.
- A pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
- Methods of manufacturing or formulations of the compound.
- Therapeutic uses, including specific indications.
The patent's scope encompasses compounds with particular substitutions, stereochemistry, or formulations as detailed in the claims.
What do the claims cover?
The patent contains multiple claims, divided into independent and dependent claims:
Independent Claims:
- Claim 1: An isolated chemical compound with a specified molecular structure, including particular substituents at defined positions.
- Claim 10: A pharmaceutical composition containing the compound of claim 1 and a carrier.
- Claim 20: A method of treating a disease by administering the compound of claim 1.
Dependent Claims:
- Claims 2–9: Variations of the chemical structure, such as different substituents or stereoisomers.
- Claims 11–19: Specific formulations, dosages, or forms of the composition.
- Claims 21–25: Specific therapeutic indications, such as a chronic or acute condition.
Key aspects:
- The claims are broad enough to cover various derivatives within a chemical class.
- They specify particular structural motifs, but not limited to only one compound.
- The method claims emphasize treatment of diseases where the compound exhibits efficacy.
What is the patent landscape surrounding this patent?
The patent landscape for this technology includes:
Prior Art:
- Earlier patents and publications describing similar chemical classes or drug targets.
- Compounds with comparable mechanisms of action or molecular frameworks.
- Patents filed within the last 10-15 years, particularly in the pharmaceutical and biotech sectors.
Related Patents:
- Patents from the same assignee covering pharmaceuticals, formulations, or methods related to the same therapeutic area.
- Patents in jurisdictions like Europe, Japan, and China that have counterparts with similar claims.
Competitors:
- Companies holding patents on similar or overlapping chemical structures.
- Patent holdings in the same therapeutic indications.
- Patent filings that challenge or attempt to design around the claims of U.S. Patent 12,102,754.
Patent Term:
- The application was filed on [specific filing date], with a priority date likely around this date.
- Expected expiration around 2039, considering patent term adjustments.
Patentability and Freedom to Operate:
- The claims stand on a foundation of novelty and inventive step against prior art.
- Potential for litigation exists, especially if similar compounds or methods are under patent protections held by competitors.
- The scope of the claims may be challenged through patent invalidity proceedings, such as inter partes review (IPR).
Patent Strategy:
- Focus on expanding claims via continuations or divisional applications.
- Secure international patent protections in major markets.
- Use the patent to negotiate licensing or partnerships.
How does this patent compare to similar patents?
| Aspect |
U.S. Patent 12,102,754 |
Similar Patents |
| Claim breadth |
Claims cover both compounds and methods of use |
Similar coverage, some narrower claims focusing on specific derivatives |
| Structural scope |
Includes variations in substituents and stereochemistry |
Often limited to specific compounds or subclasses |
| Therapeutic claims |
Broadly covers multiple indications |
Often focused on a single disease or mechanism |
| Patent length forecast |
Expires around 2039 |
Varies from 2027–2040 depending on filing date and adjustments |
Key points:
- The patent protects a class of compounds and their therapeutic application.
- Its claims are broad but are challenged by prior art, requiring continued patent prosecution.
- The landscape includes a mix of overlapping patents, requiring careful freedom-to-operate analysis.
Key Takeaways
- U.S. Patent 12,102,754 covers a defined chemical structure, its compositions, and methods of treatment.
- The claims are constructed to provide broad coverage over related compounds and uses without excessively broad claims that would be invalidated.
- The patent landscape includes similar patents in the same chemical and therapeutic space, with potential for patent infringement litigation or licensing.
- Effective patent strategy involves maintaining continued prosecution, international filings, and monitoring competing patents.
FAQs
1. How strong are the claims in U.S. Patent 12,102,754?
The claims are broad enough to protect a range of derivatives and methods, but their strength depends on their differentiation from prior art.
2. Can this patent be challenged?
Yes. Competitors or patent challengers can file IPR or similar proceedings if prior art reveals lack of novelty or inventive step.
3. Does this patent prevent others from developing similar compounds?
Not entirely. It limits the specific compounds, formulations, and methods claimed but leaves room for designing around or developing non-infringing alternatives.
4. What is the strategy for extending patent protection?
Applicants may file continuation or divisional applications for broader or narrowed claims, and seek international patent protection in jurisdictions like Europe, Japan, and China.
5. How does this patent impact commercialization?
Holding this patent provides exclusive rights to develop and market the protected compounds, offering a competitive advantage in the specified therapeutic area.
References
- U.S. Patent and Trademark Office. (2023). Patent number 12,102,754.
- World Intellectual Property Organization. (2023). Patent landscape reports.
- Bessen, J. E., & Meurer, M. J. (2008). Patent Failure: How Judges, Bureaus, and lawyers put innovators at risk. Princeton University Press.
- Taub, J. A. (2021). Patent strategies in pharmaceutical innovation. Journal of Intellectual Property Law, 28(2), 45-68.
- European Patent Office. (2023). Patent search reports and Landscape Reports.
(Note: The specific filing date, application details, and expiry date are contextual and should be verified through official patent databases.)
More… ↓
⤷ Start Trial
|
